Cure.Care’s Conflict of Interest Policy ensures that our medical content remains strictly unbiased, objective, and independent of commercial influence. We require all medical reviewers, authors, and editorial staff to proactively disclose any financial, personal, or professional relationships that could compromise the integrity of our healthcare encyclopedia.
We mandate full disclosure of any financial ties, consulting roles, or equity holdings our medical team has with pharmaceutical or device companies.
Editorial decisions are driven solely by evidence-based medicine and clinical guidelines, never by sponsors, advertisers, or partners.
We do not accept money to write, alter, or rank articles. "Sponsored" content is strictly prohibited in our disease and symptom hubs.
Failure to disclose a conflict of interest results in immediate recusal from the article, re-review of past work, and potential removal from our board.
When reviewing medical devices or supplements, our content evaluates the science, not the brand. We maintain strict neutrality.
Disclosures are not a one-time event. Our medical board updates their conflict of interest declarations annually and per-project.
A conflict of interest (COI) occurs when a reviewer or author has secondary interests—financial, personal, or professional—that could unduly influence their primary responsibility to provide accurate, unbiased medical information.
At Cure.Care, we recognize that many top medical professionals consult, research, or hold equity in healthcare companies. Having a conflict is not inherently wrong; failing to disclose it is. We require absolute transparency so our editorial team can assess and manage potential biases appropriately.
Cure.Care operates with a strict "firewall" between our commercial operations (advertising, affiliate partnerships) and our editorial content (disease hubs, articles, symptoms). The business team cannot dictate, alter, or suppress editorial content.
Our editors and medical board have final authority over all published health information. Revenue streams do not influence our clinical recommendations. Read more about this separation in our Editorial Ethics policy.
Every member of the Cure.Care Medical Board and editorial team must complete an annual COI disclosure form. Additionally, they must declare any new conflicts before reviewing a specific article. Disclosable interests include:
Cure.Care participates in affiliate programs with pharmacies, lab testing services, and supplement brands. However, these partnerships never affect our editorial ratings or recommendations. If we recommend a product, it is because our medical board deems it clinically sound.
If an article contains an affiliate link, it is clearly marked as such. The presence of an affiliate link never changes the clinical tone of the article. For full details, review our Affiliate Disclosure and Ethical Monetization Policy.
Display advertising (Stream 1 monetization) is a key revenue source for Cure.Care. However, advertisers have zero input on our editorial content. We do not write "advertorials" disguised as medical guides.
All ads are clearly labeled as "Advertisement" or "Sponsored." If an ad appears next to a competing condition's article, that is a programmatic placement, not an endorsement. Our ad placement rules are governed by the Advertising Disclosure.
To prevent even the appearance of impropriety, Cure.Care enforces a strict "no gifts" policy for its editorial and medical review staff. Reviewers may not accept meals, travel, or hospitality from pharmaceutical, biotech, or medical device companies.
If a reviewer is invited to speak at a medically relevant conference funded by an industry player, they must disclose the funding source and recuse themselves from reviewing any related content on Cure.Care for a minimum of 12 months.
If a medical reviewer declares a conflict of interest with the topic of an article, they are immediately recused from the review process. The article is reassigned to another board member with no conflicting interests.
For example, if a cardiologist on our board consults for a manufacturer of a specific statin, they cannot review our "High Cholesterol Treatment" guide. This ensures that treatment recommendations remain entirely objective. Learn more about our workflow in the Content Review Process.
Failure to disclose a conflict of interest is a serious breach of our Editorial Ethics. If a reviewer is found to have hidden a financial or personal tie to a topic they reviewed, Cure.Care takes immediate action.
Enforcement steps include: immediate removal of their byline from the article, a full re-audit of all articles they previously reviewed, publication of a correction notice, and permanent removal from the Cure.Care Medical Board. If you suspect an undisclosed conflict, please use our Report a Concern page.
Medical Disclaimer: This policy explains our editorial safeguards. It does not constitute medical advice. For health concerns, always consult a qualified healthcare professional. Read full disclaimer.